121 related articles for article (PubMed ID: 3258768)
1. Recombinant alpha 2-interferon in the treatment of B chronic lymphocytic leukemia in early stages.
Rozman C; Montserrat E; Viñolas N; Urbano-Ispizua A; Ribera JM; Gallart T; Compernolle C
Blood; 1988 May; 71(5):1295-8. PubMed ID: 3258768
[TBL] [Abstract][Full Text] [Related]
2. Recombinant leukocyte A interferon in B-cell chronic lymphocytic leukemia: in vivo effects on autologous antitumor immunity.
Schulof RS; Lloyd MJ; Stallings JJ; Mai D; Phillips TM; Jones GJ; Schechter GP
J Biol Response Mod; 1985 Jun; 4(3):310-23. PubMed ID: 3874930
[TBL] [Abstract][Full Text] [Related]
3. Recombinant alfa-2b-interferon therapy in untreated, stages A and B chronic lymphocytic leukemia. A preliminary report.
Pangalis GA; Griva E
Cancer; 1988 Mar; 61(5):869-72. PubMed ID: 3338053
[TBL] [Abstract][Full Text] [Related]
4. Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease.
Molica S; Alberti A
Haematologica; 1990; 75(1):75-8. PubMed ID: 2338291
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.
O'Connell MJ; Colgan JP; Oken MM; Ritts RE; Kay NE; Itri LM
J Clin Oncol; 1986 Feb; 4(2):128-36. PubMed ID: 3511183
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia.
Foon KA; Bottino GC; Abrams PG; Fer MF; Longo DL; Schoenberger CS; Oldham RK
Am J Med; 1985 Feb; 78(2):216-20. PubMed ID: 3970047
[TBL] [Abstract][Full Text] [Related]
7. Relationship of the clinical response and binding of recombinant interferon alpha in patients with lymphoproliferative diseases.
Faltynek CR; Princler GL; Rossio JL; Ruscetti FW; Maluish AE; Abrams PG; Foon KA
Blood; 1986 Apr; 67(4):1077-82. PubMed ID: 2937469
[TBL] [Abstract][Full Text] [Related]
8. Favorable response of early stage B CLL patients to treatment with IFN-alpha 2.
Ziegler-Heitbrock HW; Schlag R; Flieger D; Thiel E
Blood; 1989 May; 73(6):1426-30. PubMed ID: 2713486
[TBL] [Abstract][Full Text] [Related]
9. Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral mass.
Montserrat E; Villamor N; Urbano-Ispizua A; Ribera JM; Lozano M; Vives-Corrons JL; Rozman C
Ann Hematol; 1991 Jul; 63(1):15-9. PubMed ID: 1878419
[TBL] [Abstract][Full Text] [Related]
10. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.
Bunn PA; Ihde DC; Foon KA
Cancer; 1986 Apr; 57(8 Suppl):1689-95. PubMed ID: 3485012
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia--a pilot study.
Talpaz M; Rosenblum M; Kurzrock R; Reuben J; Kantarjian H; Gutterman J
Am J Hematol; 1987 Apr; 24(4):341-50. PubMed ID: 3494396
[TBL] [Abstract][Full Text] [Related]
12. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
Foon KA; Bunn PA
Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
[TBL] [Abstract][Full Text] [Related]
13. Recombinant beta-serine-interferon in hairy cell leukemia compared prospectively with results with recombinant alpha-interferon.
Glaspy JA; Marcus SG; Ambersley J; Golde DW
Cancer; 1989 Jul; 64(2):409-13. PubMed ID: 2736487
[TBL] [Abstract][Full Text] [Related]
14. Phase I-II study of recombinant alpha-2 interferon against advanced leukemia and lymphoma in children.
Ochs J; Abromowitch M; Rudnick S; Murphy SB
J Clin Oncol; 1986 Jun; 4(6):883-7. PubMed ID: 3458876
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2531-6. PubMed ID: 6594973
[TBL] [Abstract][Full Text] [Related]
16. Clinical signification of natural killer activity in B-cell chronic lymphocytic leukemia.
Alvarez-Mon M; Casas J; Laguna R; Jordá J; Durantez A
Eur J Haematol; 1987 Mar; 38(3):268-73. PubMed ID: 3496239
[TBL] [Abstract][Full Text] [Related]
17. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.
Talpaz M; Kantarjian HM; McCredie K; Trujillo JM; Keating MJ; Gutterman JU
N Engl J Med; 1986 Apr; 314(17):1065-9. PubMed ID: 3457264
[TBL] [Abstract][Full Text] [Related]
18. Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up.
Boussiotis VA; Pangalis GA
Br J Haematol; 1991 Oct; 79 Suppl 1():30-3. PubMed ID: 1931705
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of renal cell carcinoma. 3. Interferon therapy].
Kobayashi M; Imai K; Kiren H; Nakai K; Saruki K; Umeyama T; Ito Y; Yamanaka H; Makino T; Machida M
Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.
Sarna G; Pertcheck M; Figlin R; Ardalan B
Cancer Treat Rep; 1986 Dec; 70(12):1365-72. PubMed ID: 3791249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
